$NVMI Balance Sheet | Understand Stock

$NVMI

$334.72 +$7.12 (2.17%) Close

$NVMI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q4 FY2013 As of Dec 31, 2013	Q4 FY2012 As of Dec 31, 2012	Q4 FY2011 As of Dec 31, 2011
ASSETS
Current assets
Cash and cash equivalents
Held for trading securities
Available for sale securities
Short-term interest-bearing bank deposits
Marketable securities
Trade accounts receivable, net of allowance of $300 and $576 at December 31, 2025 and 2024 , respectively
Inventories
Deferred tax assets (Note 10)
Other current assets
Total current assets
Held to maturity securities

Non-current assets
Long-term interest-bearing bank deposits
Marketable securities
Interest-bearing bank deposits and restricted cash
Restricted interest-bearing bank deposits and restricted cash
Deferred tax assets (Note 11)
Deferred tax assets
Severance pay funds
Operating lease right-of-use assets
Property, plant and equipment, net
Intangible assets, net
Goodwill
Other long-term assets
Severance pay funds (Note 8)
Total non-current assets

TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities
Convertible senior notes, net
Trade accounts payable
Deferred revenues
Deferred tax liabilities (Note 10)
Operating lease current liabilities
Other current liabilities
Total current liabilities

Non-Current liabilities
Convertible senior notes, net
Accrued severance pay
Deferred revenues
Deferred tax liabilities (Note 10)
Operating lease long-term liabilities
Deferred tax liability
Other long-term liabilities
Total non-current liabilities

TOTAL LIABILITIES
SHAREHOLDERS’ EQUITY
Ordinary shares, no par value - Authorized 60,000,000 shares at December 31, 2025 and 2024 ; Issued and Outstanding 31,780,111 and 29,278,401 at December 31, 2025 and 2024, respectively.
Additional paid-in capital
Accumulated other comprehensive loss
Treasury shares
Retained earnings
Total shareholders’ equity

Total liabilities and shareholders’ equity

Comments